United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024Business Wire • 10/23/24
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual MeetingBusiness Wire • 09/24/24
United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—EverBusiness Wire • 09/10/24
United Therapeutics (UTHR) Up 9.9% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 08/30/24
Stock Market Fades Badly As Dow Jones Index Turns Back At This Critical LevelInvestors Business Daily • 08/07/24
United Therapeutics (UTHR) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 08/02/24
3 Reasons Why Growth Investors Shouldn't Overlook United Therapeutics (UTHR)Zacks Investment Research • 07/31/24
United Therapeutics Corporation Reports Second Quarter 2024 Financial ResultsBusiness Wire • 07/31/24
United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024Business Wire • 07/24/24
Is United Therapeutics (UTHR) a Solid Growth Stock? 3 Reasons to Think "Yes"Zacks Investment Research • 07/15/24
What Makes United Therapeutics (UTHR) a Strong Momentum Stock: Buy Now?Zacks Investment Research • 07/15/24